Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer

Abstract Colorectal cancer (CRC) is one of the most prevalent forms of cancer. CircRNAs have emerged as promising biomarkers for cancer diagnosis and prognosis evaluation. However, novel circRNAs as potential biomarkers for CRC still need further exploration and validation, and precise detection met...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingsong Xu, Li Cao, Shuang Yang, Ying Jian, Yu Liu, Zhen Shen, Qian Liu, Xiang Chen, Min Li, Shun Li, Xiaolei Zuo, Hua Wang
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Aggregate
Subjects:
Online Access:https://doi.org/10.1002/agt2.663
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592390995574784
author Jingsong Xu
Li Cao
Shuang Yang
Ying Jian
Yu Liu
Zhen Shen
Qian Liu
Xiang Chen
Min Li
Shun Li
Xiaolei Zuo
Min Li
Hua Wang
author_facet Jingsong Xu
Li Cao
Shuang Yang
Ying Jian
Yu Liu
Zhen Shen
Qian Liu
Xiang Chen
Min Li
Shun Li
Xiaolei Zuo
Min Li
Hua Wang
author_sort Jingsong Xu
collection DOAJ
description Abstract Colorectal cancer (CRC) is one of the most prevalent forms of cancer. CircRNAs have emerged as promising biomarkers for cancer diagnosis and prognosis evaluation. However, novel circRNAs as potential biomarkers for CRC still need further exploration and validation, and precise detection methods are yet to be developed. Herein, we report for the first time the use of droplets Cas13a to detect the circWDR37 as a biomarker of CRC. The arraystar circRNA microarray assays, functional experiments in vitro and in vivo, and qPCR were performed to discover and validate that circWDR37 is a biomarker for early screening and prognosis evaluation of CRC. A new technology named µDCR, which accurately detects circWDR37, has been developed by combining microfluidic droplets with CRISPR/Cas13a and recombinase polymerase amplification (RPA). Meanwhile, the role of crowding agent in improving the performance of Cas13a was uncovered. The 4% polyethylene glycol 8000 and 3% dextran‐10 significantly improved the response speed and sensitivity of one‐pot Cas13a‐RPA reaction. The detection limit of circWDR37 by µDCR was found to be 10 copies/mL, which is higher than that of qPCR. The clinical sample findings demonstrated that circWDR37 detection can be utilized to effectively screen for CRC at an early stage and enable accurate assessment of prognosis. CircWDR37 is confirmed as a groundbreaking biomarker for both diagnosis and prognosis evaluation in CRC patients. Furthermore, our innovative µDCR method for detecting circWDR37 demonstrates impressive attributes such as streamlined operation, rapidity, and high‐throughput, making it an optimal technology platform for the noninvasive screening of CRC.
format Article
id doaj-art-e9c4a3f3ae8948588f785735c0e42ded
institution Kabale University
issn 2692-4560
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Aggregate
spelling doaj-art-e9c4a3f3ae8948588f785735c0e42ded2025-01-21T08:57:07ZengWileyAggregate2692-45602025-01-0161n/an/a10.1002/agt2.663Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancerJingsong Xu0Li Cao1Shuang Yang2Ying Jian3Yu Liu4Zhen Shen5Qian Liu6Xiang Chen7Min Li8Shun Li9Xiaolei Zuo10Min Li11Hua Wang12Department of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Pathology, The Fifth People's Hospital of Shanghai Fudan University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaNational Key Laboratory of Science and Technology on Micro/Nano Fabrication Department of Micro/Nano Electronics Shanghai Jiao Tong University Shanghai ChinaInstitute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaShanghai Public Health Clinical Center Fudan University Shanghai ChinaInstitute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaDepartment of Laboratory Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai ChinaAbstract Colorectal cancer (CRC) is one of the most prevalent forms of cancer. CircRNAs have emerged as promising biomarkers for cancer diagnosis and prognosis evaluation. However, novel circRNAs as potential biomarkers for CRC still need further exploration and validation, and precise detection methods are yet to be developed. Herein, we report for the first time the use of droplets Cas13a to detect the circWDR37 as a biomarker of CRC. The arraystar circRNA microarray assays, functional experiments in vitro and in vivo, and qPCR were performed to discover and validate that circWDR37 is a biomarker for early screening and prognosis evaluation of CRC. A new technology named µDCR, which accurately detects circWDR37, has been developed by combining microfluidic droplets with CRISPR/Cas13a and recombinase polymerase amplification (RPA). Meanwhile, the role of crowding agent in improving the performance of Cas13a was uncovered. The 4% polyethylene glycol 8000 and 3% dextran‐10 significantly improved the response speed and sensitivity of one‐pot Cas13a‐RPA reaction. The detection limit of circWDR37 by µDCR was found to be 10 copies/mL, which is higher than that of qPCR. The clinical sample findings demonstrated that circWDR37 detection can be utilized to effectively screen for CRC at an early stage and enable accurate assessment of prognosis. CircWDR37 is confirmed as a groundbreaking biomarker for both diagnosis and prognosis evaluation in CRC patients. Furthermore, our innovative µDCR method for detecting circWDR37 demonstrates impressive attributes such as streamlined operation, rapidity, and high‐throughput, making it an optimal technology platform for the noninvasive screening of CRC.https://doi.org/10.1002/agt2.663circRNAcolorectal cancerCRISPR/Cas13acrowding agentdroplet
spellingShingle Jingsong Xu
Li Cao
Shuang Yang
Ying Jian
Yu Liu
Zhen Shen
Qian Liu
Xiang Chen
Min Li
Shun Li
Xiaolei Zuo
Min Li
Hua Wang
Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer
Aggregate
circRNA
colorectal cancer
CRISPR/Cas13a
crowding agent
droplet
title Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer
title_full Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer
title_fullStr Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer
title_full_unstemmed Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer
title_short Droplets Cas13a‐RPA measurement delineates potential role for plasma circWDR37 in colorectal cancer
title_sort droplets cas13a rpa measurement delineates potential role for plasma circwdr37 in colorectal cancer
topic circRNA
colorectal cancer
CRISPR/Cas13a
crowding agent
droplet
url https://doi.org/10.1002/agt2.663
work_keys_str_mv AT jingsongxu dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT licao dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT shuangyang dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT yingjian dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT yuliu dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT zhenshen dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT qianliu dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT xiangchen dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT minli dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT shunli dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT xiaoleizuo dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT minli dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer
AT huawang dropletscas13arpameasurementdelineatespotentialroleforplasmacircwdr37incolorectalcancer